The global cannula market size reached US$ 149.3 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 219.1 Million by 2028, exhibiting a growth rate (CAGR) of 7.1% during 2023-2028.
A cannula is a small hollow tube with a sharp and retractable inner core that is inserted into a vein, artery or body cavity to administer medication and draw off fluids. Several types of cannula are available for performing different procedures. For instance, an intravenous cannula is used in cardiac surgery by establishing cardiopulmonary bypass. Similarly, a nasal cannula is utilized for administering oxygen by running the plastic tubing beneath the nose. Additionally, it is widely used for injecting fillers as it causes lesser pain, reduces the risk of bleeding and bruising, and provides greater flexibility as compared to hypodermic needles. Owing to its numerous attributes, it finds extensive applications in hospitals, ambulatory surgery centers (ASCs), blood banks, laboratories and pathology labs across the globe.
Cannula Market Trends:
The growing global population, which is more susceptible to chronic medical disorders, represents one of the key factors positively influencing the demand for cannulas. In addition, changing dietary patterns and the rising prevalence of lifestyle diseases, such as obesity, diabetes, and hypertension, are increasing the number of surgical procedures, which, in turn, is contributing to the market growth. Along with this, rising incidences of cardiovascular diseases and the shifting preference toward minimally invasive surgeries (MIS) are propelling the market growth. Besides this, the increasing influence of social media and the growing traction of cosmetic surgeries are creating a positive outlook for the market. Furthermore, governments of various countries are introducing numerous policies for providing primary healthcare services, coupled with continuous advancements in healthcare facilities, which are further bolstering the market growth. Moreover, increasing investments by leading market players in research and development (R&D) activities to introduce more advanced product variants are anticipated to drive the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cannula market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application, type, size, material and end user.
Breakup by Product:
- Cardiac Cannulas
- Nasal Cannulas
- Vascular Cannulas
- Dermatology Cannulas
- Arthroscopy Cannulas
Cardiac cannulas currently represent the largest market segment due to the growing global population and the rising prevalence of cardiovascular diseases across the globe.
Breakup by Type:
- Neonatal Cannulas
- Straight Cannulas
- Winged Cannula
- Wing with Port Cannula
Straight cannulas are the most used variants as they are equipped with an extra sharp needle that makes it easier to insert into veins or arteries.
Breakup by Size:
18 G cannulas account for the majority of the global cannula market share as they are extensively used in hospitals to infuse products and deliver medications.
Breakup by Material:
- Plastic (PVC) Cannulas
- Silicone Cannulas
- Metal Cannulas (Stainless Steel)
Plastic (PVC) cannulas currently hold the largest market share due to their widespread adoption in both in-patient and out-patient procedures.
Breakup by Application:
- Cardiovascular Surgery
- Oxygen Therapy
- General Surgery
- Cosmetic/Plastic Surgery
- Orthopedic Surgery
Breakup by End-User:
- Ambulatory Surgery Centers (ASCs)
Hospitals presently dominate the market on account of the rising prevalence of chronic medical disorders and increasing accidents and the hospitalization rate.
Breakup by Region:
- North America
- Asia Pacific
- South Korea
- United Kingdom
- Latin America
- Middle East and Africa
The competitive landscape of the industry has also been examined with some of the key players being Boston Scientific Corporation, CONMED Corporation, Edwards Lifesciences, Medtronic Plc, Smith & Nephew PLC, Smiths Medical Inc., LivaNova Plc, Teleflex Incorporated, Terumo Corporation, etc.
|Base Year of the Analysis
||Product, Application, Type, Size, Material, End User, Region
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||Boston Scientific Corporation, CONMED Corporation, Edwards Lifesciences, Medtronic Plc, Smith & Nephew PLC, Smiths Medical Inc., LivaNova Plc, Teleflex Incorporated and Terumo Corporation
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)